Barclays’s HealthEquity HQY Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $3.29M | Sell |
36,443
-13,679
| -27% | -$1.16M | ﹤0.01% | 2072 |
|
|
2026
Q1 | $4.19M | Sell |
50,122
-134,982
| -73% | -$11.1M | ﹤0.01% | 1928 |
|
|
2025
Q4 | $17M | Sell |
185,104
-29,187
| -14% | -$2.79M | ﹤0.01% | 1341 |
|
|
2025
Q3 | $20.3M | Buy |
214,291
+13,922
| +7% | +$1.31M | ﹤0.01% | 1229 |
|
|
2025
Q2 | $21M | Buy |
200,369
+70,134
| +54% | +$6.65M | ﹤0.01% | 1107 |
|
|
2025
Q1 | $11.5M | Sell |
130,235
-70,106
| -35% | -$7.19M | ﹤0.01% | 1306 |
|
|
2024
Q4 | $19.2M | Buy |
200,341
+33,849
| +20% | +$3.15M | 0.01% | 1149 |
|
|
2024
Q3 | $13.6M | Buy |
166,492
+112,667
| +209% | +$8.69M | ﹤0.01% | 1268 |
|
|
2024
Q2 | $4.64M | Sell |
53,825
-134,688
| -71% | -$10.9M | ﹤0.01% | 1595 |
|
|
2024
Q1 | $15.4M | Sell |
188,513
-3,270
| -2% | -$255K | 0.01% | 1132 |
|
|
2023
Q4 | $12.7M | Buy |
191,783
+136,643
| +248% | +$9.47M | ﹤0.01% | 1337 |
|
|
2023
Q3 | $4.03M | Sell |
55,140
-8,041
| -13% | -$543K | ﹤0.01% | 1459 |
|
|
2023
Q2 | $3.99M | Buy |
63,181
+9,670
| +18% | +$561K | ﹤0.01% | 1473 |
|
|
2023
Q1 | $3.14M | Buy |
53,511
+20,193
| +61% | +$1.23M | ﹤0.01% | 1867 |
|
|
2022
Q4 | $2.05M | Buy |
33,318
+13,465
| +68% | +$905K | ﹤0.01% | 2251 |
|
|
2022
Q3 | $1.33M | Buy |
19,853
+11,941
| +151% | +$756K | ﹤0.01% | 2019 |
|
|
2022
Q2 | $486K | Sell |
7,912
-7,761
| -50% | -$497K | ﹤0.01% | 2885 |
|
|
2022
Q1 | $1.06M | Sell |
15,673
-98,018
| -86% | -$5.29M | ﹤0.01% | 2352 |
|
|
2021
Q4 | $5.03M | Buy |
113,691
+24,386
| +27% | +$1.42M | ﹤0.01% | 1712 |
|
|
2021
Q3 | $5.78M | Buy |
89,305
+28,547
| +47% | +$1.98M | ﹤0.01% | 1529 |
|
|
2021
Q2 | $4.89M | Sell |
60,758
-17,386
| -22% | -$1.32M | ﹤0.01% | 1591 |
|
|
2021
Q1 | $5.31M | Buy |
78,144
+37,481
| +92% | +$2.94M | ﹤0.01% | 1474 |
|
|
2020
Q4 | $2.83M | Sell |
40,663
-56,373
| -58% | -$3.51M | ﹤0.01% | 1964 |
|
|
2020
Q3 | $4.98M | Buy |
97,036
+19,224
| +25% | +$1.06M | ﹤0.01% | 1400 |
|
|
2020
Q2 | $4.56M | Buy |
77,812
+46,825
| +151% | +$2.59M | ﹤0.01% | 1450 |
|
|
2020
Q1 | $1.57M | Sell |
30,987
-46,636
| -60% | -$3.1M | ﹤0.01% | 2508 |
|
|
2019
Q4 | $5.75M | Buy |
77,623
+40,143
| +107% | +$2.5M | ﹤0.01% | 1861 |
|
|
2019
Q3 | $2.14M | Sell |
37,480
-40,871
| -52% | -$2.71M | ﹤0.01% | 2778 |
|
|
2019
Q2 | $5.12M | Buy |
78,351
+29,131
| +59% | +$2.03M | ﹤0.01% | 1839 |
|
|
2019
Q1 | $3.64M | Buy |
49,220
+22,579
| +85% | +$1.59M | ﹤0.01% | 1949 |
|
|
2018
Q4 | $1.59M | Sell |
26,641
-31,369
| -54% | -$2.53M | ﹤0.01% | 2638 |
|
|
2018
Q3 | $5.48M | Buy |
58,010
+28,824
| +99% | +$2.48M | ﹤0.01% | 1719 |
|
|
2018
Q2 | $2.19M | Sell |
29,186
-22,076
| -43% | -$1.59M | ﹤0.01% | 2507 |
|
|
2018
Q1 | $3.1M | Sell |
51,262
-4,922
| -9% | -$266K | ﹤0.01% | 2031 |
|
|
2017
Q4 | $2.62M | Buy |
56,184
+46,145
| +460% | +$2.28M | ﹤0.01% | 2194 |
|
|
2017
Q3 | $508K | Sell |
10,039
-53,392
| -84% | -$2.49M | ﹤0.01% | 3610 |
|
|
2017
Q2 | $3.16M | Buy |
63,431
+46,852
| +283% | +$2.19M | ﹤0.01% | 1839 |
|
|
2017
Q1 | $703K | Sell |
16,579
-14,651
| -47% | -$648K | ﹤0.01% | 3069 |
|
|
2016
Q4 | $1.27M | Buy |
31,230
+30,115
| +2,701% | +$1.16M | ﹤0.01% | 2523 |
|
|
2016
Q3 | $42K | Buy |
+1,115
| New | +$35.3K | ﹤0.01% | 5072 |
|
|
2016
Q1 | – | Sell |
-58
| Closed | -$1K | – | 6253 |
|
|
2015
Q4 | $1K | Sell |
58
-132
| -69% | -$4.06K | ﹤0.01% | 5823 |
|
|
2015
Q3 | $6K | Sell |
190
-504
| -73% | -$15.8K | ﹤0.01% | 5986 |
|
|
2015
Q2 | $22K | Buy |
694
+379
| +120% | +$10.2K | ﹤0.01% | 5621 |
|
|
2015
Q1 | $7K | Sell |
315
-535
| -63% | -$11.6K | ﹤0.01% | 6424 |
|
|
2014
Q4 | $21K | Buy |
+850
| New | +$18.4K | ﹤0.01% | 6297 |
|
Other funds holding HQY
WA
Barclays's HQY Position: Q2 2026 in Review
Barclays reduced its HealthEquity (HQY) stake by 27% in Q2 2026, selling an estimated $1.16M and leaving 36,443 shares worth $3.29M. The position accounts for ﹤0.01% of the portfolio, ranked #2072.
Barclays first reported a position in HQY in Q4 2014 and has held it in 45 quarters since. The position peaked at $21M in Q2 2025. 500 funds tracked by Wall St. Rank hold HQY as of Q2 2026.
- Barclays held 36,443 shares of HealthEquity worth $3.29M as of Q2 2026.
- Barclays sold 13,679 HealthEquity shares in Q2 2026, an estimated $1.16M.
- HealthEquity made up ﹤0.01% of Barclays's portfolio in Q2 2026, its #2072 holding.
- Barclays first reported a position in HealthEquity in Q4 2014 and has held it in 45 quarters since.
- Barclays's HealthEquity position peaked at $21M in Q2 2025.
- 500 funds tracked by Wall St. Rank held HealthEquity as of Q2 2026.
Based on Barclays's 13F filing for Q2 2026, filed 14 Aug 2026.